Full Year 2025 Glanbia PLC Earnings Call Transcript
Key Points
- Glanbia PLC (GLAPF) reported robust performance in 2025 with like-for-like revenue and volume growth across all segments, driven by strong consumer demand for better nutrition brands and ingredients.
- The company raised its interim dividend by 10% and returned approximately EUR197 million to shareholders via share buyback programs, with a further EUR100 million authorized for 2026.
- Glanbia PLC (GLAPF) made significant progress on its group-wide transformation program, expected to generate annual cost savings of at least EUR60 million by 2027.
- The Health & Nutrition segment delivered strong performance with like-for-like revenue growth of 6.8%, driven by volume increases and strategic acquisitions.
- The company successfully expanded its international presence, particularly in China, India, Oceania, and the UK, with strong growth in the Optimum Nutrition brand.
- Glanbia PLC (GLAPF) experienced a decrease in pre-exceptional EBITDA by 9.4% and a contraction in EBITDA margins due to elevated whey input costs.
- Performance Nutrition EBITDA declined by 23.2%, with margins impacted by record whey input costs.
- The company faced headwinds in the US club and specialty channels, affecting revenue growth in the Performance Nutrition Americas segment.
- There was a negative impact on pricing in the Health & Nutrition segment due to certain pass-through pricing of customers.
- The company incurred exceptional charges of over $100 million related to its transformation program and losses on disposals of noncore brands.
Good day and thank you for standing by. Welcome to the Glanbia 2025 full year results presentation. (Operator Instructions). Please be advised that today's conference is being recorded. I will now hand over to Liam Hennigan, Group Secretary and Head of Investor Relations, to open the presentation. Please go ahead.
Thank you. Good morning, and welcome to the Glanbia full year 2025 results call. During today's call, the Directors may make forward-looking statements. These statements have been made by the directors in good faith based on the information available to them up to the time of their approval of the full year 2025 results.
Due to the inherent uncertainties, including both economic and business risk factors underlying such forward-looking information, actual results may differ materially from those expressed or implied by these forward-looking statements.
The Directors undertake no obligation to update any forward-looking information made on today's call, whether
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
